Anthropometric models to estimate fat mass at 3 days, 15 and 54 weeks.
Autorzy:
Gopalakrishnamoorthy M; Division of Pediatric Endocrinology, Columbia University Irving Medical Center, New York, New York, USA. Whyte K; Division of Endocrinology, Department of Medicine, New York Nutrition Obesity Research Center, Columbia University Irving Medical Center, New York, New York, USA. Horowitz M; Division of Endocrinology, Department of Medicine, New York Nutrition Obesity Research Center, Columbia University Irving Medical Center, New York, New York, USA. Widen E; Division of Endocrinology, Department of Medicine, New York Nutrition Obesity Research Center, Columbia University Irving Medical Center, New York, New York, USA.; Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University.; Department of Nutritional Sciences, The University of Texas at Austin, Austin, Texas, USA. Toro-Ramos T; Division of Endocrinology, Department of Medicine, New York Nutrition Obesity Research Center, Columbia University Irving Medical Center, New York, New York, USA. Johnson J; Division of Endocrinology, Department of Medicine, New York Nutrition Obesity Research Center, Columbia University Irving Medical Center, New York, New York, USA. Gidwani S; Department Pediatrics, Mount Sinai West Hospital, Mount Sinai Health System, Icahn School of Medicine, New York, New York, USA. Paley C; Department Pediatrics, Mount Sinai West Hospital, Mount Sinai Health System, Icahn School of Medicine, New York, New York, USA. Rosenn B; Department of Obstetrics and Gynecology, Mount Sinai West Hospital, Mount Sinai Health System, Icahn School of Medicine, New York, New York, USA. Lin S; Center for Family and Community Medicine, Columbia University, New York, New York, USA. Thornton J; Consultant, New York, New York, USA. Pi-SunyerX; Division of Endocrinology, Department of Medicine, New York Nutrition Obesity Research Center, Columbia University Irving Medical Center, New York, New York, USA.; Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University. Gallagher D; Division of Endocrinology, Department of Medicine, New York Nutrition Obesity Research Center, Columbia University Irving Medical Center, New York, New York, USA.; Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University.
Pokaż więcej
Źródło:
Pediatric obesity [Pediatr Obes] 2022 Mar; Vol. 17 (3), pp. e12855. Date of Electronic Publication: 2021 Sep 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Empowering patients with comorbid diabetes and hypertension through a multi-component intervention of mobile app, health coaching and shared decision-making: Protocol for an effectiveness-implementation of randomised controlled trial.
Feasibility study of Glucagon-like peptide-1 analogues for the optimization of Outcomes in obese patients undergoing AbLation for Atrial Fibrillation (GOAL-AF) protocol.
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program.
Emergent Management of Gastric Outlet Obstruction Post-Intragastric Balloon: A Case Report Highlighting the Importance of Preoperative Assessments and Postoperative Monitoring in Obesity Management.
The Role of the Dysregulated JNK Signaling Pathway in the Pathogenesis of Human Diseases and Its Potential Therapeutic Strategies: A Comprehensive Review.
Perceived weight stigma in healthcare settings among adults living with obesity: A cross‐sectional investigation of the relationship with patient characteristics and person‐centred care.
Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials.
Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.
A technology-assisted health coaching intervention vs. enhanced usual care for Primary Care-Based Obesity Treatment: a randomized controlled trial.
Autorzy:
Viglione C; 1Veteran Affairs New York Harbor Healthcare System & NYU School of Medicine, New York, USA. Bouwman D; 2NYU School of Medicine & Veteran Affairs New York Harbor Healthcare System, New York, USA. Rahman N; 3NYU Langone Health & Veteran Affairs New York Harbor Healthcare System, New York, USA. Fang Y; 4New Jersey Institute of Technology, New York, USA. Beasley JM; 5NYU School of Medicine, New York, USA. Sherman S; 1Veteran Affairs New York Harbor Healthcare System & NYU School of Medicine, New York, USA. Pi-SunyerX; 6Columbia University Medical Center, New York, USA. Wylie-Rosett J; 7Albert Einstein College of Medicine, New York, USA. Tenner C; 1Veteran Affairs New York Harbor Healthcare System & NYU School of Medicine, New York, USA. Jay M; 1Veteran Affairs New York Harbor Healthcare System & NYU School of Medicine, New York, USA.
Pokaż więcej
Źródło:
BMC obesity [BMC Obes] 2019 Feb 04; Vol. 6, pp. 4. Date of Electronic Publication: 2019 Feb 04 (Print Publication: 2019).
Islet autoantibody positivity in overweight and obese adults with type 2 diabetes.
Autorzy:
Pilla SJ; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA. Balasubramanyam A; b Baylor College of Medicine , Houston , TX , USA. Knowler WC; c National Institute of Diabetes and Digestive and Kidney Diseases , Phoenix , AZ , USA. Lazo M; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA.; d Department of Epidemiology , The Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA. Nathan DM; e Massachusetts General Hospital and Harvard Medical School , Boston , MA , USA. Pi-SunyerX; f Columbia University Medical Center , New York , NY , USA. Clark JM; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA.; d Department of Epidemiology , The Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA. Maruthur NM; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA.; d Department of Epidemiology , The Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes.
Participants stories about long-term achievement 60-months after attending a Healthy Life Centre programme (the VEND-RISK study) - a qualitative study.
Association between body mass index (BMI) and [I]Ioflupane (DaTSCAN) availabilities in patients with parkinsonism using single-photon emission computed tomography–computed tomography (SPECT-CT).
The (cost) effectiveness of a very low-energy diet intervention with the use of eHealth in patients with type 2 diabetes and obesity: study protocol for a randomised controlled non-inferiority trial (E-diet trial).
Bioactive Properties, Bioavailability Profiles, and Clinical Evidence of the Potential Benefits of Black Pepper (Piper nigrum) and Red Pepper (Capsicum annum) against Diverse Metabolic Complications.
Correcting calculation and data errors reveals that the original conclusions were incorrect in "The best drug supplement for obesity treatment: a systematic review and network meta-analysis".
Association between physical activity education and prescription during prenatal care and maternal and fetal health outcomes: a quasi-experimental study.
Poria cocos compounds targeting neuropeptide Y1 receptor (Y1R) for weight management: A computational ligand- and structure-based study with molecular dynamics simulations identified beta-amyrin acetate as a putative Y1R inhibitor.
Position statement on nutrition therapy for overweight and obesity: nutrition department of the Brazilian association for the study of obesity and metabolic syndrome (ABESO—2022).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
